Tags: Chemoimmunotherapy
Choosing Between Novel Agents and Chemoimmunotherapy in CLL
H&O Which novel agents are available for physicians treating patients with chronic lymphocytic leukemia? JW Right now, we have Bruton tyrosine kinase (BTK) inhibitors, phosphoinositide-3 […]